Amit Singhal to Antitubercular Agents
This is a "connection" page, showing publications Amit Singhal has written about Antitubercular Agents.
Connection Strength
0.978
-
Cheng CY, B?hme J, Singhal A. Metabolic energy sensors as targets for designing host-directed therapies for tuberculosis. J Leukoc Biol. 2018 02; 103(2):215-223.
Score: 0.505
-
Rossouw J, Wallis R, Kornfeld H, Singhal A, Maartens G, Wiesner L, Denti P, Wasmann RE. The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis. Antimicrob Agents Chemother. 2026 Sep 02; 70(9):e0074826.
Score: 0.229
-
Haver HL, Chua A, Ghode P, Lakshminarayana SB, Singhal A, Mathema B, Wintjens R, Bifani P. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2015 Sep; 59(9):5316-23.
Score: 0.106
-
Mani V, Wang S, Inci F, De Libero G, Singhal A, Demirci U. Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care. Adv Drug Deliv Rev. 2014 Nov 30; 78:105-17.
Score: 0.098
-
Pisu D, Huang L, Narang V, Theriault M, L?-Bury G, Lee B, Lakudzala AE, Mzinza DT, Mhango DV, Mitini-Nkhoma SC, Jambo KC, Singhal A, Mwandumba HC, Russell DG. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med. 2021 09 06; 218(9).
Score: 0.040